000 01272 a2200349 4500
005 20250516175850.0
264 0 _c20140408
008 201404s 0 0 eng d
022 _a1945-7197
024 7 _a10.1210/jc.2013-3031
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVellanki, Priyathama
245 0 0 _aDenosumab for management of parathyroid carcinoma-mediated hypercalcemia.
_h[electronic resource]
260 _bThe Journal of clinical endocrinology and metabolism
_cFeb 2014
300 _a387-90 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAdult
650 0 4 _aAntibodies, Monoclonal, Humanized
_xtherapeutic use
650 0 4 _aCarcinoma
_xcomplications
650 0 4 _aDenosumab
650 0 4 _aHumans
650 0 4 _aHypercalcemia
_xdrug therapy
650 0 4 _aMale
650 0 4 _aParathyroid Neoplasms
_xcomplications
650 0 4 _aTreatment Outcome
700 1 _aLange, Karoline
700 1 _aElaraj, Dina
700 1 _aKopp, Peter A
700 1 _aEl Muayed, Malek
773 0 _tThe Journal of clinical endocrinology and metabolism
_gvol. 99
_gno. 2
_gp. 387-90
856 4 0 _uhttps://doi.org/10.1210/jc.2013-3031
_zAvailable from publisher's website
999 _c23219710
_d23219710